Skip to main content
. 2021 Dec 14;11:23950. doi: 10.1038/s41598-021-03480-9

Table 3.

Comparison of glycemic parameters across 48-week study (x¯ ± s).

Group n HbA1C(%) TIR(%) IQR
(mmol/L)
MBG(mmol/L) Hypoglycemic duration(min/d)
FGM 71
1 W 9.05 ± 1.43 36.49 ± 17.57 8.39 ± 2.69 11.79 ± 2.20 201.96 ± 44.28
24 W 8.16 ± 1.03 49.39 ± 17.54 6.85 ± 2.35 10.48 ± 1.63 175.86 ± 43.19
48 W 7.39 ± 0.71 62.35 ± 12.29 5.70 ± 2.03 9.21 ± 1.18 158.78 ± 35.31
SMBG 75
1 W 9.07 ± 1.18 37.87 ± 15.87 8.10 ± 1.94 11.81 ± 1.93 198.13 ± 35.90
24w 8.68 ± 1.01* 42.44 ± 15.49* 7.57 ± 1.81* 11.22 ± 1.60* 191.95 ± 37.11*
48w 8.36 ± 1.02** 46.52 ± 16.65** 7.10 ± 1.91** 10.78 ± 1.62** 192.80 ± 31.08**

TIR: time in range; IQR: interquartile range; MBG: mean blood glucose; Hypoglycemic duration: the time below 3.9 mmol/l.

*: Compared with FGM at 24 W, p < 0.05; **: Compared with FGM at 48 W, p < 0.01.